Purchase Order N0025922P0256
Award Date 10/1/22
Potential Completion Date 9/30/23
Potential Value $250K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92134, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price purchase order awarded by the Defense Health Agency (DHA) to Karius, Inc. for quantitative next-generation sequencing testing services. The $240,000 contract supports DHA programs through September 2023 and leverages Karius' expertise in genomic sequencing to rapidly screen patients for various pathogens. This is a sole source award, as Karius is the only commercial laboratory capable of providing the requested cell-free DNA testing from plasma samples with 24-72...
- This federal contract award is for a Quantitative Next-Gen Sequencing Test to be provided to the Naval Medical Center San Diego Lab Department. The $240,000.00 firm fixed-price purchase order was awarded to Karius, Inc., a life sciences company specializing in advanced molecular diagnostic testing and next-generation sequencing technologies. The contract, which does not have a set-aside designation, has an ultimate completion date of September 30, 2027 and was awarded on October 1, 2023....
- The Department of Veterans Affairs, through Veterans Integrated Service Network 8, awarded a delivery order valued at $46,000 to Karius, Inc. for the provision of next-generation sequencing (NGS) testing services. This delivery order, effective through July 31, 2025, represents the third year of testing delivery under a firm fixed-price contract structure with no set-aside designation. Karius, Inc., headquartered in Redwood City, California, is a specialized life sciences company focused on...
- The U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 8 has awarded Karius, Inc. a firm-fixed-price delivery order contract for its Karius Next Generation Sequencing (NGS) diagnostic test. The contract has a ceiling value of $60,000 and a performance period from August 1, 2023 to July 31, 2024. This award is part of a larger $600,000 Indefinite Delivery Contract (IDC) that Karius holds with the VA VHA, which has an ultimate completion date of July 31, 2027. The...
- This contract was awarded by the National Institutes of Health (NIH) Clinical Center to Karius, Inc., a life sciences company specializing in diagnostic testing for infectious diseases. The contract, valued at $80,000.00, is for the provision of molecular diagnostic testing services using Karius' liquid biopsy technology to rapidly screen patients for various pathogens. The testing services will be delivered within 3-4 days of specimen receipt. This is a firm fixed-price purchase order...
- On April 1, 2025, the Department of Veterans Affairs, Veterans Integrated Service Network 17, awarded a delivery order valued at $22,000 to Karius, Inc. under contract 36C25725D0031 (Order #36C25725N0219). This firm fixed-price delivery order, with an ultimate completion date of March 31, 2026, represents performance at the contractor's location in Harlingen, Texas. The award was issued without set-aside designation and leverages Karius, Inc.'s specialized capabilities in next-generation...
- This is a $44,000 firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Karius, Inc., a life sciences company specializing in advanced molecular diagnostic testing and next-generation sequencing (NGS) technologies focused on infectious disease detection. The contract is for the procurement of molecular diagnostic testing services, with an ultimate completion date of September 14, 2026. Karius, Inc. has previously held Indefinite Delivery...
- This is a firm-fixed-price definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian federal agency, to Karius, Inc., a life sciences company based in Redwood City, California. The contract, valued at $630,976.00, is for research and development related to metagenomic sequencing of microbial cell-free DNA and RNA for comprehensive pathogen detection. This contract does not have a set-aside designation, indicating Karius competed as a...
- The Defense Health Agency awarded a $5.42 million firm fixed-price purchase order to Biofire Defense LLC on October 1, 2025, for molecular infectious disease polymerase chain reaction (PCR) testing services. The contract, which carries no set-aside designation, is scheduled for completion by September 30, 2030, and will be performed at Biofire Defense's facility in San Antonio, Texas. This award leverages Biofire Defense's established expertise in advanced diagnostic solutions, particularly...
- The Defense Health Agency (DHA) awarded a $3.5 million firm fixed-price purchase order to Biofire Defense LLC on September 30, 2024, for molecular diagnostic kits with a completion date of September 29, 2029. This contract, which includes no set-aside designation, will be performed in Bethesda, Maryland. Biofire Defense is a specialized manufacturer of biological agent identification and molecular diagnostic solutions based in Salt Lake City, Utah, known for its FilmArray and RAZOR Mk II systems...